Common questions about Lertazin (FAQ)
Q: How long does it typically take before Lertazin starts working?
The official product information indicates that Lertazin acts rapidly. The highest concentration of the medicine in the blood, known as peak plasma concentration, is typically reached in approximately 0.9 hours after taking the tablet form in adults. For the oral solution, this peak concentration is reached even faster, in about 0.5 hours.
Q: What information is available about Lertazin use during pregnancy?
According to the official drug prescribing information, Lertazin is assigned to Pregnancy Category B. This classification means that while initial studies in animals showed no harm to the fetus, research in pregnant women is limited. Official sources state that this medicine is intended for use during pregnancy only if it is clearly needed.
Q: Is Lertazin considered a controlled substance?
Official documents confirm that Lertazin (levocetirizine) is not classified as a controlled substance. It is not listed under the U.S. Controlled Substances Act (CSA) schedule.
Q: Are there warnings about driving or operating machinery while on Lertazin?
Official warnings caution against performing tasks that require complete mental alertness, such as driving a vehicle or operating heavy machinery. This caution is included because fatigue, drowsiness (somnolence), and loss of strength (asthenia) have been reported.
Q: What is the risk of dependence or withdrawal with Lertazin?
Official postmarketing reports have documented cases of new onset, severe itching (pruritus) that may occur a few days after stopping the medicine, especially following long-term use. The product label suggests consulting a healthcare provider if symptoms occur, as improvement has been noted when the medicine is restarted or tapered.
Q: What is the purpose of the boxed warning (if any) on Lertazin?
Lertazin does not currently have a Boxed Warning, which is the most stringent type of warning mandated by the FDA. However, the FDA has required the addition of a specific warning regarding the risk of severe itching upon discontinuation after long-term use.
Q: Can patients with kidney problems use Lertazin?
Official documents state that use is prohibited (contraindicated) for patients with end-stage renal disease (severe kidney failure). For adults and adolescents 12 years and older with mild to moderate kidney issues, a specific dose adjustment and monitoring may be necessary. The medicine is also prohibited for children under 12 years of age with any degree of impaired kidney function.
Q: What is the difference between brand-name Lertazin and generic versions?
The FDA has determined that generic versions of Lertazin contain the same active ingredient and are considered equally effective as the brand-name product. The primary differences are typically related to cost and the non-active ingredients, such as the fillers used in the formulation.
Q: Can Lertazin be used for anxiety that is not related to its main use?
Official information states the drug is only indicated for allergic rhinitis and chronic idiopathic urticaria, which are its approved uses. Postmarketing surveillance reports have documented cases of psychiatric effects, including anxiety and aggression, but these are noted as potential adverse reactions, not indications for use.
Q: Is Lertazin known to cause any skin reactions or rashes?
Studies show Lertazin is indicated to help manage the skin-related symptoms of chronic idiopathic urticaria (hives or itching). However, rare but serious side effects, including severe hypersensitivity reactions and swelling of the face or throat (angioneurotic edema), are listed in the official adverse reactions section.
Q: Does Lertazin affect birth control pills?
Official regulatory drug labels and interaction resources do not list a specific interaction between Lertazin and hormonal oral contraceptives (birth control pills).
Q: Does Lertazin interact with caffeine?
Official drug interaction resources generally do not list a specific interaction with caffeine. The official label does warn that the medicine should be avoided with alcohol or other central nervous system (CNS) depressants due to potential additive effects on alertness.
Q: Can Lertazin be taken with antacids or heartburn medication?
The official drug label notes that Lertazin can be taken without regard to food consumption. No specific interaction between Lertazin and common antacids or heartburn medication is listed in the official prescribing information.
Q: Why is Lertazin sometimes called by its generic name?
Regulatory and scientific sources often refer to the medicine by its generic name, which is levocetirizine dihydrochloride. The generic name is the standardized, non-proprietary chemical name for the drug's active ingredient and is used to ensure clarity across all medical and pharmacological references.
Q: Does taking Lertazin require regular blood tests or monitoring?
Routine blood tests or clinical monitoring are not explicitly mandated for all patients in the standard prescribing information. However, the initial research protocols for the drug did require regular monitoring of certain lab parameters, such as kidney and liver function.
Q: Can Lertazin be used by children?
Lertazin is generally allowed for children 6 months of age and older for certain indications, with specific lower doses outlined in the label. However, official safety information states that use is not appropriate (contraindicated) for children between 6 months and 11 years of age who have any degree of impaired kidney function.
